Hemoglobin Disorders in Egypt: Sickle Cell Disease Ain Shams University Institutional Registry (Egyptian SCD)

August 30, 2026 updated by: Fatma Soliman Elsayed Ebeid, MD, Ain Shams University
This is a retrospective descriptive study to create an institutional registry that will continue as a prospective follow-up non-intervention study that will be carried out at Hematology Oncology and BMT Department, Children's Hospital, Ain-Shams University, Cairo, Egypt.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Egypt
      • Cairo, Egypt, 11566
        • Recruiting
        • Faculty of Medicine Ain Shams Research Institute- Clinical Research Center
        • Contact:
      • Cairo, Egypt
        • Active, not recruiting
        • Faculty of medicine ain shams university

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

children, adolescents and young adults with sickle cell disease who were following at Hematology Oncology and BMT Unit, Children's Hospital, Ain Shams University from the initiation of clinic in 1975 till 01 Jan 2027.

Description

Inclusion Criteria:

  • children, adolescents and young adults with sickle cell disease

Exclusion Criteria:

  • other inherited anemia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Children, adolescents and young adults with sickle cell disease
We will start with those who were/are following at Hematology Oncology and BMT Unit, Children's Hospital, Ain Shams University

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Institutional database
Time Frame: 2 years
To create databases and institutional registry for managing the clinical data
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ain Shams University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 17, 2024

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

March 1, 2027

Study Registration Dates

First Submitted

August 30, 2026

First Submitted That Met QC Criteria

August 30, 2026

First Posted (Actual)

September 2, 2026

Study Record Updates

Last Update Posted (Actual)

September 2, 2026

Last Update Submitted That Met QC Criteria

August 30, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FMASU P08/2024

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe